Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-26T00:16:17.710Z.
Calculation as of: 2026-09-26T00:16:17.710Z.
Quote observation: 2026-09-25T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 10fdbeb150bcad31bc030c110c9f0c4a3b87f33d2b32019f4e65bb0dcc9467f6
PEG RATIO
N/A
West Pharmaceutical Services, Inc.
Market Cap
$26.06B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $26.06B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $26.08B | N/A |
| Labcorp Holdings Inc. (LH)vs › | $25.39B | N/A |
| Incyte Corporation (INCY)vs › | $25.11B | N/A |
| BioNTech SE (BNTX)vs › | $24.75B | N/A |
| Medline Inc. (MDLN)vs › | $29.34B | N/A |
| Zoetis Inc. (ZTS)vs › | $29.79B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.10B | N/A |
| Centene Corp. (CNC)vs › | $30.53B | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $30.55B | N/A |
PEG Ratio
N/A
P/E Ratio
47.4
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
